位置:首页 > 蛋白库 > LANLB_BACLD
LANLB_BACLD
ID   LANLB_BACLD             Reviewed;          69 AA.
AC   P86720;
DT   05-OCT-2010, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 1.
DT   25-MAY-2022, entry version 29.
DE   RecName: Full=Lantibiotic lichenicidin A2 {ECO:0000303|PubMed:19561184, ECO:0000303|PubMed:19707558};
DE            Short=LchA2 {ECO:0000250|UniProtKB:P86476};
DE   AltName: Full=BliA2 {ECO:0000303|PubMed:19561184};
DE   Flags: Precursor;
GN   Name=lanA2 {ECO:0000303|PubMed:19561184};
GN   Synonyms=licA2 {ECO:0000303|PubMed:19707558};
GN   OrderedLocusNames=BLi04126.1, BL05375.1;
OS   Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / CCUG 7422 /
OS   NBRC 12200 / NCIMB 9375 / NCTC 10341 / NRRL NRS-1264 / Gibson 46).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=279010;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 14580 / DSM 13 / JCM 2505 / CCUG 7422 / NBRC 12200 / NCIMB 9375
RC   / NCTC 10341 / NRRL NRS-1264 / Gibson 46;
RX   PubMed=15383718; DOI=10.1159/000079829;
RA   Veith B., Herzberg C., Steckel S., Feesche J., Maurer K.H., Ehrenreich P.,
RA   Baeumer S., Henne A., Liesegang H., Merkl R., Ehrenreich A., Gottschalk G.;
RT   "The complete genome sequence of Bacillus licheniformis DSM13, an organism
RT   with great industrial potential.";
RL   J. Mol. Microbiol. Biotechnol. 7:204-211(2004).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 14580 / DSM 13 / JCM 2505 / CCUG 7422 / NBRC 12200 / NCIMB 9375
RC   / NCTC 10341 / NRRL NRS-1264 / Gibson 46;
RX   PubMed=15461803; DOI=10.1186/gb-2004-5-10-r77;
RA   Rey M.W., Ramaiya P., Nelson B.A., Brody-Karpin S.D., Zaretsky E.J.,
RA   Tang M., Lopez de Leon A., Xiang H., Gusti V., Clausen I.G., Olsen P.B.,
RA   Rasmussen M.D., Andersen J.T., Joergensen P.L., Larsen T.S., Sorokin A.,
RA   Bolotin A., Lapidus A., Galleron N., Ehrlich S.D., Berka R.M.;
RT   "Complete genome sequence of the industrial bacterium Bacillus
RT   licheniformis and comparisons with closely related Bacillus species.";
RL   Genome Biol. 5:R77.1-R77.12(2004).
RN   [3] {ECO:0000305}
RP   IDENTIFICATION, FUNCTION, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY.
RX   PubMed=19561184; DOI=10.1128/aem.00730-09;
RA   Begley M., Cotter P.D., Hill C., Ross R.P.;
RT   "Identification of a novel two-peptide lantibiotic, lichenicidin, following
RT   rational genome mining for LanM proteins.";
RL   Appl. Environ. Microbiol. 75:5451-5460(2009).
RN   [4] {ECO:0000305}
RP   IDENTIFICATION, FUNCTION, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY.
RX   PubMed=19707558; DOI=10.1371/journal.pone.0006788;
RA   Dischinger J., Josten M., Szekat C., Sahl H.G., Bierbaum G.;
RT   "Production of the novel two-peptide lantibiotic lichenicidin by Bacillus
RT   licheniformis DSM 13.";
RL   PLoS ONE 4:E6788-E6788(2009).
CC   -!- FUNCTION: Lanthionine-containing peptide antibiotic (lantibiotic)
CC       active on Gram-positive bacteria. The bactericidal activity of
CC       lantibiotics is based on depolarization of energized bacterial
CC       cytoplasmic membranes, initiated by the formation of aqueous
CC       transmembrane pores. When present individually, LchA2 exhibits activity
CC       towards L.lactis HP. When combined with LchA1, it displays activity
CC       towards a broad spectrum of non-pathogenic and pathogenic Gram-positive
CC       bacteria including strains of L.monocytogenes, methicillin-resistant
CC       S.aureus, S.pneumoniae and strains of vancomycin-resistant enterococci,
CC       but not towards E.faecium L4001 and BM4147-1. Combined LchA1 and LchA2
CC       peptides also inhibit Bacillus sp. HIL-Y85/54728, L.lactis DPC3417 and
CC       B.halodurans C-125, which produce lantibiotics themselves. Inactivated
CC       by proteinase K and pronase E, but not by trypsin and chymotrypsin.
CC       {ECO:0000269|PubMed:19561184, ECO:0000269|PubMed:19707558}.
CC   -!- SUBCELLULAR LOCATION: Secreted, cell wall {ECO:0000269|PubMed:19561184,
CC       ECO:0000269|PubMed:19707558}.
CC   -!- PTM: Maturation of lantibiotics involves the enzymatic conversion of
CC       Thr, and Ser into dehydrated AA and the formation of thioether bonds
CC       with cysteine. This is followed by membrane translocation and cleavage
CC       of the modified precursor (By similarity).
CC       {ECO:0000250|UniProtKB:O87237}.
CC   -!- MASS SPECTROMETRY: Mass=3020.5; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:19561184, ECO:0000269|PubMed:19707558};
CC   -!- MASS SPECTROMETRY: Mass=3020.6; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:19561184, ECO:0000269|PubMed:19707558};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE017333; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CP000002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; P86720; -.
DR   SMR; P86720; -.
DR   Proteomes; UP000000606; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0009275; C:Gram-positive-bacterium-type cell wall; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:UniProtKB-KW.
DR   GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   InterPro; IPR027632; Lant_SP_1948.
DR   Pfam; PF16934; Mersacidin; 1.
DR   TIGRFAMs; TIGR03893; lant_SP_1948; 1.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; Bacteriocin; Cell wall; Lantibiotic;
KW   Reference proteome; Secreted; Thioether bond.
FT   PROPEP          1..37
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT                   /id="PRO_0000399040"
FT   PEPTIDE         38..69
FT                   /note="Lantibiotic lichenicidin A2"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT                   /id="PRO_0000399041"
FT   MOD_RES         38
FT                   /note="2-oxobutanoic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         39
FT                   /note="(Z)-2,3-didehydrobutyrine"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         42
FT                   /note="(Z)-2,3-didehydrobutyrine"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         43
FT                   /note="(Z)-2,3-didehydrobutyrine"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         45
FT                   /note="2,3-didehydroalanine (Ser)"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         50
FT                   /note="(Z)-2,3-didehydrobutyrine"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         54
FT                   /note="(Z)-2,3-didehydrobutyrine"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   MOD_RES         63
FT                   /note="(Z)-2,3-didehydrobutyrine"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   CROSSLNK        44..48
FT                   /note="Lanthionine (Ser-Cys)"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   CROSSLNK        56..60
FT                   /note="Lanthionine (Ser-Cys)"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   CROSSLNK        62..65
FT                   /note="Beta-methyllanthionine (Thr-Cys)"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
FT   CROSSLNK        66..69
FT                   /note="Beta-methyllanthionine (Thr-Cys)"
FT                   /evidence="ECO:0000250|UniProtKB:P86476"
SQ   SEQUENCE   69 AA;  7088 MW;  72F41C9E5C7FD3B6 CRC64;
     MKNSAAREAF KGANHPAGMV SEEELKALVG GNDVNPETTP ATTSSWTCIT AGVTVSASLC
     PTTKCTSRC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024